Summary
The benzamide-derivative moclobemide (Ro 11-1163) is a new short-acting, reversible MAO-inhibitor, preferentially affecting Type A MAO, which is, being developed as an antidepressant agent. The effect of moclobemide on heart rate, blood pressure, electrocardiographic and systolic time intervals was assessed in eight healthy volunteers and seven depressive patients. The volunteers received single doses of 100 mg, 150 mg and placebo in radomized single-blind order. Seven patients received placebo and 100 mg as single doses and five patients were also given chronic treatment with individually assessed optimal therapeutic dose (100–400 mg). No change in blood pressure, heart rate, ECG or systolic time intervals was found. The compound was well tolerated. The findings suggest that moclobemide may be a safe MAO-inhibitor as far as sympathetic responsiveness and cardiovascular effects are concerned.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bobon DP, Rossignol P, Lepage-Goffioul G, Adens A, Gilot P, Breulet M (1979) L'effet antidepressif du Ro 11-1163, inhibiteur selectif de la MAO-A. Congres de Psychiatrie et de Neurologie, Angers, pp 1281–1286
Casacchia M, Carolei A, Argenta G, Castellana F, Baldassare M, Fazio C (1981) Antidepressant activity of Ro 11-1163 a new MAO-inhibitor. Abstract, International Symposium on Typical and Atypical Antidepressants, Taormina, March 25–29
Da Prada M, Keller HH, Kettler R, Schaffner R, Pieri M, Burkhard WP, Korn A, Haefely WE (1982) Ro 11-1163, a specific and short-acting MAO-inhibitor with antidepressant properties. In: Kamijo K, Usdin E, Nagatsu T (eds) Monoamine oxidase, basic and clinical frontiers. Excerpta Medica, Amsterdam Oxford Princeton, pp 183–196
Gibson DG (1978) Use of the systolic time intervals in clinical pharmacology. Br J Clin Pharmacol 6: 97–102
Kopin IJ, Fischer JE, Musacchio JM, Musacchio JM, Horst WD, Weise VK (1965) False neurochemical transmitters and the mechanism of sympathetic blockade by monoamine oxidase inhibitors. J Pharmacol 147: 186–193
Kopin IJ (1982) False transmitters revisited: Their role in the hypotensive action of MAO-inhibitor. In: Kamijo K, Usdin E, Nagatsu T (eds) Monoamine oxidase, basic and clinical frontiers. Excerpta Medica, Amsterdam Oxford Princeton, pp 321–327
Korn A, Gasic S, Müller R, Hitzenberger G (1980) A new monoamine oxidase inhibitor which exerts a slightly increased tyramine sensitivity in man only. Abstr. Nr. 569, Abstract Book, World Conference on Clinical Pharmacology and Therapeutics, London, August 3–9
Lewis RP, Rittgers SE, Forester WF, Boudoulas H (1977) A critical review of the systolic time intervals. Circulation 56: 146–158
Stefanis CN, Alevizos BH, Papdimitrion GN (1982) Antidepressant effect of Ro 11-1163, a new MAO-inhibitor. Int Pharmacopsychiatr 17 [1]: 43–48
Weissler AM (1977) Current concepts in cardiology: Systolictime intervals. N Engl J Med 296: 321–324
Weissler AM, Kamen AR, Bornstein RS, Schoenfeld CD, Cohen S (1965) Effect of deslanoside on the duration of the phases of ventricular systole in man. Am J Cardiol 15: 153–161
Weissler AM, Lewis RP, Schoenfeld CD (1969) Bedside technics for the evaluation of ventricular function in man. Am J Cardiol 23: 577–583
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gasic, S., Korn, A., Eichler, H.G. et al. Cardiocirculatory effects of moclobemide (Ro 11-1163), a new reversible, a short-acting MAO-inhibitor with preferential Type A inhibition, in healthy volunteers and depressive patients. Eur J Clin Pharmacol 25, 173–177 (1983). https://doi.org/10.1007/BF00543787
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00543787